MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The spectrum of GBA mutations in the Korean population with Parkinson’s disease

J. Hwangbo, J. Lee, SC. Cheon, KS. Park (Yangsan, Republic of Korea)

Meeting: 2023 International Congress

Abstract Number: 1084

Keywords: Lysosomal disorders, Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: We investigated the mutation spectrum of glucocerebrosidase (GBA) gene in Korean patients with Parkinson’s disease (GBA-PD).

Background: Mutations in the GBA gene represent important genetic risk factors for PD. The pathogenicity of different variants varies largely. To date, over 100 different GBA mutations have been reported, with ethnic differences in the mutational spectrum. However, there are few studies on the mutation spectrum of GBA-PD in Koreans.

Method: Fifty Korean patients with GBA-PD were enrolled in this study. We identified 25 PD patients by sequencing the entire GBA gene. In addition, 25 PD patients were recruited through review of two previously reported literatures. The pathogenicity of GBA mutations is classified as ‘severe’ or ‘mild’ based on the established risks reported for PD.

Results: Seventeen different mutations were detected. Eleven mutations (p.L483P [n = 9, previously known as L444P], p.R296Q [n = 8, R257Q], p.N227S [n = 4, N188S], p.F252I [n = 4, F213I], p.R159W [n = 3, R120W], c.115+1G>A [n = 3, IVS2 + 1], p.D448H [n = 2, D409H], p.V230G [n = 2, V191G], p.P240H [n = 2, P201H], Rec1; p.L483P, p.A495P, p.V499V [n = 2, RecNciI; L444P+A456P+V460V], p.R202* [n = 1, R163X],) are known to be associated with Gaucher’s disease (GD) and PD and are classified as severe mutations for developing PD. p.S310G [n = 4, S271G] and p.N409S [n = 1, N370S] are classified as mild variants. p.N431S [n = 2, N392S], has already been reported in PD, but the significance of PD remains unknown. p.G85E [n = 2, G46E], p.P221L [n = 1, P182L] have been reported in GD, but not reported in PD. One patient had compound heterozygous mutations (p.P240H, p.N431S). One novel variant (p.I442V) that is likely pathogenic was found to have unknown significance based on the American College of Medical Genetics and Genomics guidelines. p.E365K (E326K) and p.T408M (T369M) were absent.

Conclusion: Various GBA mutations were identified in the Korean GBA-PD patients. p.L483P and p.R296Q were the two most common mutations. Some risk variants common in the western countries were rare in the Korean population.

To cite this abstract in AMA style:

J. Hwangbo, J. Lee, SC. Cheon, KS. Park. The spectrum of GBA mutations in the Korean population with Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/the-spectrum-of-gba-mutations-in-the-korean-population-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-spectrum-of-gba-mutations-in-the-korean-population-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley